Rallybio RLYB
NASDAQ RLYB
$15.80 +0.04 (+0.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Rallybio (RLYB) Tax Rate (2026)

Updated

Rallybio's Tax Rate was 2.94% in Q2 2026.

Analysis

Rallybio (RLYB) Tax Rate (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 23.26%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 12.61%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 8.85%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.54%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 20.70%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.96%
10 Rallybio 84.05 Mn -201.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.94%
API Access

Rallybio Tax Rate API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-rate&ticker=RLYB&period=max&api_key=YOUR_API_KEY